New Jersey Man's Diabetes Condition Improving after Stem Cell Therapy in Germany
Retired New Jersey firefighter is reporting decreased insulin doses and lower blood glucose levels within one month after his adult stem cell treatment for diabetes (type 2), diabetes induced erectile dysfunction and peripheral artery disease in Cologne, Germany.
Cologne, Germany (PRWEB) June 19, 2007 -- Retired Fire Captain, Calvin Miller of Union City, New Jersey is reporting decreased insulin doses and lower blood glucose levels within one month after his adult stem cell treatment for diabetes (type 2) , diabetes induced erectile dysfunction and peripheral artery disease in Cologne, Germany.
Mr. Miller was recently treated at the XCell-Center using adult stem cells derived from a small amount of his own bone marrow. The stem cells were introduced directly into his pancreas using a minimally invasive catheter procedure via the right femoral artery. To battle the common diabetes complications of peripheral artery disease and erectile dysfunction, stem cells were also introduced into his thighs and calves, and into the arteries that supply the penis, respectively.
"Before scuba diving this past Sunday morning, I injected only 32% of my normal insulin dose. During the day, I ate normally - for a diabetic - without injecting any more insulin. That evening, I measured my blood sugar and I was astounded that it was only 126. A month ago, even with my full insulin doses, I never had readings below 170," said Miller.
These are the third, fourth and fifth diseases in two years for which Mr. Miller has chosen to undergo stem cell therapy. After being treated with stem cells for coronary artery disease in January 2005, he was featured in BusinessWeek Magazine (June 2005) . In September 2005, he was treated for ischemic cardiomyopathy using minimally invasive surgery.
"Actually, what really got my attention this past weekend was that I also felt a regeneration of heart function…and that was after a 3 km swim," Miller added with a grin.
About the XCell-Center
The XCell-Center is the first privately-owned center in Europe to specialize in regenerative medicine using autologous adult stem cell therapy. Newly completed in 2006, the XCell-Center features the latest medical equipment and technology. The XCell-Center is a fully licensed clinic with German specialized physicians working in accordance with German law and European guidelines. It is located on the second floor wing of the Eduardus Hospital in Cologne, Germany.
The XCell-Center currently treats Diabetes and its complications (Erectile Dysfunction and Peripheral Artery Disease), Stroke, Spinal Cord Injuries, Ischemic Heart Disease and degenerative diseases such as Multiple Sclerosis, Parkinson's and Alzheimer's.
Before the end of this year, the XCell-Center will publish clinical data coming from their SCIDEM I and II trials. In these trials, diabetes (type I and II) patients will be treated with their own stem cells and compared with a control group receiving traditional therapy. The findings will be presented at different international scientific meetings. Later this year, another clinical trial for stroke patients will commence.
For more information on Stem Cell Therapy:
XCell-Center Website: http://www.xcell-center.com
Stem Cell Therapy for Diabetes Blog: http://www.stem-cell-diabetes.blogspot.com
XCell-Center GmbH
at the Institute for Regenerative Medicine
Custodisstrasse 3-17
Cologne, Germany 50679
E-Mail: info @ xcell-center.de
Phone: 1-866-680-8202 (USA Toll-Free) or (+49) 0221-802-5095 (Germany)
Fax: 1-713-583-9322 (USA) or (+49) 0221-2921-2550 (Germany)
###
|
